Posttraumatic Stress Disorder
- Author: T Allen Gore, MD, MBA, CMCM, DFAPA; Chief Editor: Iqbal Ahmed, MBBS, FRCPsych (UK) more...
Background
The formal diagnosis of posttraumatic stress disorder (PTSD) was not introduced into the Diagnostic and Statistical Manual of Mental Disorders (DSM) until its third publication, in 1980. In earlier DSM editions, this relatively new diagnosis was characterized as stress response syndrome, a type of gross stress reaction, or a situational disorder, and was often incorrectly associated with personal weakness instead of situational trauma.[1]
PTSD is now defined as a pathological anxiety that usually occurs after an individual experiences or witnesses severe trauma that constitutes a threat to the physical integrity or life of the individual or of another person.
The individual initially responds with intense fear, helplessness, or horror. The person later develops a response to the event that is characterized by persistently reexperiencing the event, with resultant symptoms of numbness, avoidance, and hyperarousal.[2] These symptoms result in clinically significant distress or functional impairment. To meet the full criteria for PTSD, these symptoms should be present for a minimum of 1 month following the initial traumatic event.
The events experienced may be natural disasters, violent personal assaults, war, severe automobile accidents, or the diagnosis of a life-threatening condition. For children, a developmentally inappropriate sexual experience may be considered a traumatic event, even though it may not have actually involved violence or physical injury.
Brain structures associated with the body’s reaction to fear and stress can be seen in the image below.
Brain structures involved in dealing with fear and stress. PTSD can be acute (symptoms lasting < 3 mo), chronic (symptoms lasting ≥ 3 mo), or of delayed onset (6 mo elapses from event to symptom onset).
Studies have pointed to a new, dissociative subtype of PTSD, with clinical and neurobiologic features that distinguish it from the nondissociative form. This dissociative subtype is described as an overmodulation of affect, or a form of emotion dysregulation, and is mediated by midline prefrontal inhibition of limbic regions. These findings are important in the treatment of PTSD, because patients can now be assessed for dissociative symptoms and treated accordingly.[3]
Complications of PTSD
Individuals with PTSD may have an increased risk of impulsive behavior, suicide, and homicide. Victims of sexual assault are at especially high risk for developing mental health problems and committing suicide.
Persons with PTSD may also be at increased risk for panic disorder, agoraphobia, obsessive-compulsive disorder, social phobia, specific phobia, major depressive disorder, and somatization disorder.
One study associated PTSD with a risk of developing dementia among older US male veterans. In a group of male veteran participants, those diagnosed with PTSD were twice as likely to develop dementia as were those without PTSD. Discovering the biological link between these disorders would be a monumental accomplishment in the fight to reduce the occurrence of dementia in PTSD victims.[4]
The legal system and PTSD
One major reason for litigation in the event of trauma and criminal offenses is to punish persons involved in violence and criminal activity. As a witness to an act of violence, the victim has an obligation to report the crime and to cooperate with law enforcement officials.
This may involve testifying before a grand jury, which occurs before the case formally begins.
The victim acts as a witness to the case and, therefore, is not a party to the criminal proceedings and is not represented. This can be difficult after experiencing the event itself, which characterizes loss of power, control, and dignity.
Victims often require the support and advocacy of legal representation, but the system does not provide it. The prosecuting attorney is the supposed advocate for the victim, but the attorney's job of defending the interests of justice may conflict with the interests of the victim.
The process of a trial can be very traumatic for the victim, particularly in cases of sexual trauma. Defense tactics sometimes involve blaming the victim for the crime by tainting his or her character; this may add more pain to an already painful process.
Go to Anxiety Disorders for more complete information on this topic.
Etiology
When PTSD occurs, symptoms of PTSD usually begin within 3 months of the traumatic event. However, a delay of months or years may occur before symptoms appear.
Physiologic factors
The amygdala is a key brain structure implicated in PTSD. Research has shown that exposure to traumatic stimuli can lead to fear conditioning, with resultant activation of the amygdala and associated structures, such as the hypothalamus, locus ceruleus, periaqueductal gray, and parabrachial nucleus. This activation and the accompanying autonomic neurotransmitter and endocrine activity produce many of the symptoms of PTSD.
The orbitoprefrontal cortex exerts an inhibiting effect on this activation. The hippocampus also may have a modulating effect on the amygdala. However, in people who develop PTSD, the orbitoprefrontal cortex appears to be less capable of inhibiting this activation, possibly due to stress-induced atrophy of specific nuclei in this region.[5, 6]
Risk factors
As mentioned, PTSD is caused by experiencing, witnessing, or being confronted with an event involving serious injury, death, or threat to the physical integrity of an individual, along with a response involving helplessness and/or intense fear or horror. In various studies, a direct relationship has been observed between the severity of the trauma and the risk of developing PTSD.[7]
When these events involve an individual with a physiologic vulnerability based on genetic (inherited) contributions and other personal characteristics, PTSD results. These personal characteristics include prior exposure to trauma, childhood adversity (eg, separation from parents), and preexisting anxiety or depression.
One of the most pivotal observations in relation to the development of PTSD in adults who were traumatized as children is the association between early trauma exposure and subsequent retraumatization.[8]
Researchers have identified factors that interact to influence vulnerability to developing PTSD.[9, 10] These factors include the following:
- Characteristics of the trauma exposure itself
- Characteristics of the individual
- Posttrauma factors
Regarding characteristics of the trauma exposure itself, factors that influence the development of PTSD include the trauma’s proximity and severity, as well as the duration of an individual’s exposure to the trauma
Characteristics of the individual that increase vulnerability to PTSD include prior trauma exposures, family history or prior psychiatric illness, and sex (women are at greatest risk for many of the most common assertive traumas).
Posttrauma factors that influence whether PTSD develops include availability of social support, emergence of avoidance or numbing, hyperarousal, and reexperiencing symptoms.
With regard to reexperiencing symptoms, a pilot monozygotic twin study showed that patients with PTSD have impaired extinction of novel conditioned fear stimuli.[11]
Combat and PTSD
Approximately 30% of men and women who have spent time in a war zone experience PTSD.[12]
Studies conducted with veteran participants from Operation Iraqi Freedom and Operation Enduring Freedom (Afghanistan) determined a strong correlation between duration of combat exposure and PTSD. Service members from Operation Enduring Freedom (Afghanistan) reported less combat experience and, consequently, a lower incidence of mental health disorder compared with veterans of Operation Iraqi Freedom, who reported greater combat exposure.[13, 14] A study by Polusney et al suggests that combat-related PTSD is strongly associated with postconcussive symptoms and psychosocial outcomes one year after return from Iraq; however, little evidence of a long-term negative impact due to concussion and mild traumatic brain injury after accounting for PTSD.[15]
Epidemiology
Incidence of PTSD in the United States
PTSD has a lifetime prevalence of 8-10% and accounts for considerable disability and morbidity. One study found the prevalence of PTSD in a sample of adolescent boys to be 3.7% and the prevalence in adolescent girls to be 6.3%.[16]
Sex preference in PTSD
Females may be at higher risk for PTSD than are males. An epidemiologic survey of adult women indicated alarmingly high rates of traumatic events, particularly events associated with being crime victims. Sexual assault probably has the most impact on women, and trauma from combat probably has the most impact on men.
Although earlier veteran studies were somewhat inconsistent, subsequent studies have suggested that service in Operation Iraqi Freedom presented equal PTSD risk to both sexes, with the duration and severity of combat experience having a greater influence than sex on the likelihood of a veteran having PTSD.[17, 18]
Age preference in PTSD
PTSD can occur in persons of any age, including children.
Prognosis
Prognosis in cases of PTSD is difficult to determine, because it varies significantly from patient to patient. Some individuals who do not receive care gradually recover over a period of years. Many individuals who receive appropriate medical and psychiatric care recover completely (or nearly completely). Rarely, even with intensive intervention, individuals experience worsening symptoms and commit suicide.
In patients with PTSD who are receiving treatment, the average duration of symptoms is 36 months, compared with 64 months for those patients who do not receive treatment. However, more than one third of patients who have PTSD never fully recover.
Factors associated with a good prognosis include rapid engagement of treatment, early and ongoing social support, avoidance of retraumatization, positive premorbid function, and an absence of other psychiatric disorders or substance abuse.
Results from a pilot study in civilians suggested that patients with PTSD who experienced peritraumatic tonic immobility during the traumatic event have a poor response to pharmacologic treatment.[19]
Patient Education
When a family member is diagnosed with PTSD, the entire family may be affected. Members may experience shock, fear, anger, and pain because of their concern for the victim. Living with family members who have PTSD does not cause PTSD. Yet, it can cause some similar symptoms, such as feelings of alienation from and anger toward the victim. Other family members may find it difficult to communicate with a person with PTSD. Sleep disturbance and abuse (physical and substance) may occur among family members.
Families should engage in counseling if anger, addiction, or problems in school or work become issues. Stress and anger management and couples' therapy are possibilities. Families should try to maintain their outside relationships and should continue to be involved in pleasurable activities.
For patient education information, see eMedicine's Mental Health and Behavior Center, as well as Post-traumatic Stress Disorder (PTSD) and Stress.
The following Web sites also provide valuable information for patients and their families: US Department of Veteran Affairs National Center for PTSD, US Army Office of Behavioral Health, Afterdeployment.org, National Institute of Mental Health, American Academy of Child and Adolescent Psychiatry, and Mayo Clinic.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision, DSM-VI-TR. In: Anxiety Disorders. Washington, DC: American Psychiatric Association; 2000:463-8.
Risser HJ, Hetzel-Riggin MD, Thomsen CJ, McCanne TR. PTSD as a mediator of sexual revictimization: the role of reexperiencing, avoidance, and arousal symptoms. J Trauma Stress. Oct 2006;19(5):687-98. [Medline].
Yaffe K, Vittinghoff E, Lindquist K, Barnes D, Covinsky KE, Neylan T, et al. Posttraumatic stress disorder and risk of dementia among US veterans. Arch Gen Psychiatry. Jun 2010;67(6):608-13. [Medline]. [Full Text].
Lanius RA, Vermetten E, Loewenstein RJ, Brand B, Schmahl C, Bremner JD, et al. Emotion modulation in PTSD: Clinical and neurobiological evidence for a dissociative subtype. Am J Psychiatry. Jun 2010;167(6):640-7. [Medline].
Medina J. Stress, PTSD and the Hippocampus. Presented at: 16th Annual US Psychiatric and Mental Health Congress. Orlando, FL: November 6-9, 2003.
Smith ME. Bilateral hippocampal volume reduction in adults with post-traumatic stress disorder: a meta-analysis of structural MRI studies. Hippocampus. 2005;15(6):798-807. [Medline].
de Quervain DJ, Margraf J. Glucocorticoids for the treatment of post-traumatic stress disorder and phobias: a novel therapeutic approach. Eur J Pharmacol. Apr 7 2008;583(2-3):365-71. [Medline].
Krahé B, Scheinberger-Olwig R, Waizenhöfer E, Kolpin S. Childhood sexual abuse and revictimization in adolescence. Child Abuse Negl. Apr 1999;23(4):383-94. [Medline].
Deykin EY. Posttraumatic Stress Disorder in Childhood and Adolescence: A Review. 1999. Medscape Mental Health [online]. Available at http://medscape.com.
Marshall RD, Pierce D. Implications of recent findings in posttraumatic stress disorder and the role of pharmacotherapy. Harv Rev Psychiatry. Jan-Feb 2000;7(5):247-56. [Medline].
Milad MR, Orr SP, Lasko NB, Chang Y, Rauch SL, Pitman RK. Presence and acquired origin of reduced recall for fear extinction in PTSD: results of a twin study. J Psychiatr Res. Jun 2008;42(7):515-20. [Medline]. [Full Text].
Johnson H, Thompson A. The development and maintenance of post-traumatic stress disorder (PTSD) in civilian adult survivors of war trauma and torture: a review. Clin Psychol Rev. Jan 2008;28(1):36-47. [Medline].
Hoge CW, Auchterlonie JL, Milliken CS. Mental health problems, use of mental health services, and attrition from military service after returning from deployment to Iraq or Afghanistan. JAMA. Mar 1 2006;295(9):1023-32. [Medline].
Hoge CW, Castro CA, Messer SC, McGurk D, Cotting DI, Koffman RL. Combat duty in Iraq and Afghanistan, mental health problems, and barriers to care. N Engl J Med. Jul 1 2004;351(1):13-22. [Medline].
Polusny MA, Kehle SM, Nelson NW, Erbes CR, Arbisi PA, Thuras P. Longitudinal effects of mild traumatic brain injury and posttraumatic stress disorder comorbidity on postdeployment outcomes in national guard soldiers deployed to Iraq. Arch Gen Psychiatry. Jan 2011;68(1):79-89. [Medline].
American Psychiatric Association. High Percentage of Youth in the U.S. Report Symptoms of Posttraumatic Stress and Other Disorders [press release]. Washington, DC: American Psychiatric Association; Aug 3 2003.
Hoge CW, Clark JC, Castro CA. Commentary: women in combat and the risk of post-traumatic stress disorder and depression. Int J Epidemiol. Apr 2007;36(2):327-9. [Medline].
Rona RJ, Fear NT, Hull L, Wessely S. Women in novel occupational roles: mental health trends in the UK Armed Forces. Int J Epidemiol. Apr 2007;36(2):319-26. [Medline].
Fiszman A, Mendlowicz MV, Marques-Portella C, Volchan E, Coutinho ES, Souza WF, et al. Peritraumatic tonic immobility predicts a poor response to pharmacological treatment in victims of urban violence with PTSD. J Affect Disord. Apr 2008;107(1-3):193-7. [Medline].
National Institute of Mental Health. Helping Children and Adolescents Cope with Violence and Disasters. NIH Publication No. 01-3518. Bethesda, Md:. National Institute of Mental Health; 2001:[Full Text].
Sonne SC, Back SE, Diaz Zuniga C, Randall CL, Brady KT. Gender differences in individuals with comorbid alcohol dependence and post-traumatic stress disorder. Am J Addict. Oct-Dec 2003;12(5):412-23. [Medline].
Schwartz AC, Bradley R, Penza KM, Sexton M, Jay D, Haggard PJ, et al. Pain medication use among patients with posttraumatic stress disorder. Psychosomatics. Mar-Apr 2006;47(2):136-42. [Medline]. [Full Text].
Olsson KA, Kenardy JA, De Young AC, Spence SH. Predicting children's post-traumatic stress symptoms following hospitalization for accidental injury: combining the Child Trauma Screening Questionnaire and heart rate. J Anxiety Disord. Dec 2008;22(8):1447-53. [Medline].
Dickie EW, Brunet A, Akerib V, Armony JL. An fMRI investigation of memory encoding in PTSD: influence of symptom severity. Neuropsychologia. Apr 2008;46(5):1522-31. [Medline].
Rodriguez BF, Weisberg RB, Pagano ME, Machan JT, Culpepper L, Keller MB. Mental health treatment received by primary care patients with posttraumatic stress disorder. J Clin Psychiatry. Oct 2003;64(10):1230-6. [Medline].
Kasai K, Yamasue H, Gilbertson MW, Shenton ME, Rauch SL, Pitman RK. Evidence for acquired pregenual anterior cingulate gray matter loss from a twin study of combat-related posttraumatic stress disorder. Biol Psychiatry. Mar 15 2008;63(6):550-6. [Medline]. [Full Text].
Högberg G, Pagani M, Sundin O, Soares J, Aberg-Wistedt A, Tärnell B, et al. Treatment of post-traumatic stress disorder with eye movement desensitization and reprocessing: outcome is stable in 35-month follow-up. Psychiatry Res. May 30 2008;159(1-2):101-8. [Medline].
Ponniah K, Hollon SD. Empirically supported psychological treatments for adult acute stress disorder and posttraumatic stress disorder: a review. Depress Anxiety. 2009;26(12):1086-109. [Medline].
Bronson D, Franco K, Budur K. Posttraumatic stress disorder in primary care patients. Compr Ther. Winter 2007;33(4):208-15. [Medline].
Litz BT, Engel CC, Bryant RA, Papa A. A randomized, controlled proof-of-concept trial of an Internet-based, therapist-assisted self-management treatment for posttraumatic stress disorder. Am J Psychiatry. Nov 2007;164(11):1676-83. [Medline].
Germain A, Shear MK, Hall M, Buysse DJ. Effects of a brief behavioral treatment for PTSD-related sleep disturbances: a pilot study. Behav Res Ther. Mar 2007;45(3):627-32. [Medline].
Raskind MA, Peskind ER, Hoff DJ, Hart KL, Holmes HA, Warren D, et al. A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder. Biol Psychiatry. Apr 15 2007;61(8):928-34. [Medline].
Lambert MT. Aripiprazole in the management of post-traumatic stress disorder symptoms in returning Global War on Terrorism veterans. Int Clin Psychopharmacol. May 2006;21(3):185-7. [Medline].
Bandelow B. Defining response and remission in anxiety disorders: toward an integrated approach. CNS Spectr. Oct 2006;11(10 Suppl 12):21-8. [Medline].
Connor KM, Davidson JR. Further psychometric assessment of the TOP-8: a brief interview-based measure of PTSD. Depress Anxiety. 1999;9(3):135-7. [Medline].
Hamilton A. Diagnosis and rating of anxiety. Special Publication: Br J Psychiatry; 1969:3:76-79.
Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. Dec 1967;6(4):278-96. [Medline].
Sheehan DV, Harnett-Sheehan K, Raj BA. The measurement of disability. Int Clin Psychopharmacol. Jun 1996;11 Suppl 3:89-95. [Medline].
Connor KM, Sutherland SM, Tupler LA, Malik ML, Davidson JR. Fluoxetine in post-traumatic stress disorder. Randomised, double-blind study. Br J Psychiatry. Jul 1999;175:17-22. [Medline].
Davis LL, Frazier EC, Williford RB, Newell JM. Long-term pharmacotherapy for post-traumatic stress disorder. CNS Drugs. 2006;20(6):465-76. [Medline].
Pollack MH, Hoge EA, Worthington JJ, et al. Eszopiclone for the treatment of posttraumatic stress disorder and associated insomnia: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry. Jul 2011;72(7):892-7. [Medline].
Brunet A, Orr SP, Tremblay J, Robertson K, Nader K, Pitman RK. Effect of post-retrieval propranolol on psychophysiologic responding during subsequent script-driven traumatic imagery in post-traumatic stress disorder. J Psychiatr Res. May 2008;42(6):503-6. [Medline].
Krystal JH, Rosenheck RA, Cramer JA, Vessicchio JC, Johnes, KM, et al. Adjunctive risperidone treatment for antidepressant-resistant symptoms of chronic military service-related PTSD. JAMA. Aug 2011;306(5):461-568.
[Best Evidence] Bisson JI, Ehlers A, Matthews R, Pilling S, Richards D, Turner S. Psychological treatments for chronic post-traumatic stress disorder. Systematic review and meta-analysis. Br J Psychiatry. Feb 2007;190:97-104. [Medline].
Bremner JD. Neuroimaging in posttraumatic stress disorder and other stress-related disorders. Neuroimaging Clin N Am. Nov 2007;17(4):523-38, ix. [Medline]. [Full Text].

